H3 Biomedicine Inc., a start-up focused on cancer treatments based on genetics, officially unveiled its new office in Cambridge yesterday. Todd R. Golub, HMS professor of pediatrics at the Dana-Farber Cancer Institute, is one of the scientific founders of the company.
